ACS Omega (Feb 2021)
Amlexanox Enhances Temozolomide-Induced Antitumor Effects in Human Glioblastoma Cells by Inhibiting IKBKE and the Akt-mTOR Signaling Pathway
- Jinbiao Xiong,
- Gaochao Guo,
- Lianmei Guo,
- Zengguang Wang,
- Zhijuan Chen,
- Yang Nan,
- Yiyao Cao,
- Ruilong Li,
- Xuejun Yang,
- Jun Dong,
- Xun Jin,
- Weidong Yang,
- Qiang Huang
Affiliations
- Jinbiao Xiong
- Department of Neurosurgery, Tianjin Medical University General Hospital, Tianjin, China
- Gaochao Guo
- Department of Neurosurgery, Tianjin Medical University General Hospital, Tianjin, China
- Lianmei Guo
- Department of Neurosurgery, Tianjin Medical University General Hospital, Tianjin, China
- Zengguang Wang
- Department of Neurosurgery, Tianjin Medical University General Hospital, Tianjin, China
- Zhijuan Chen
- Department of Neurosurgery, Tianjin Medical University General Hospital, Tianjin, China
- Yang Nan
- Department of Neurosurgery, Tianjin Medical University General Hospital, Tianjin, China
- Yiyao Cao
- Department of Neurosurgery, Tianjin Medical University General Hospital, Tianjin, China
- Ruilong Li
- Department of Neurosurgery, Tianjin Medical University General Hospital, Tianjin, China
- Xuejun Yang
- Department of Neurosurgery, Tianjin Medical University General Hospital, Tianjin, China
- Jun Dong
- Department of Neurosurgery, The Second Affiliated Hospital of Soochow University, Suzhou, China
- Xun Jin
- Tianjin Medical University Cancer Institute and Hospital, Tianjin, China
- Weidong Yang
- Department of Neurosurgery, Tianjin Medical University General Hospital, Tianjin, China
- Qiang Huang
- Department of Neurosurgery, Tianjin Medical University General Hospital, Tianjin, China
- DOI
- https://doi.org/10.1021/acsomega.0c05399
- Journal volume & issue
-
Vol. 6,
no. 6
pp. 4289 – 4299
Abstract
No abstracts available.
